Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Martin Borg
Impact of Gemcitabine Chemotherapy and 3-Dimensional Conformal Radiation Therapy/5-Fluorouracil on Quality of Life of Patients Managed for Pancreatic Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Related publications
Quality of Life in Metastatic Pancreatic Cancer Patients Receiving Liposomal Irinotecan Plus 5-Fluorouracil and Leucovorin
European Journal of Cancer
Cancer Research
Oncology
Health-Related Quality-Of-Life After External Beam Radiation Therapy for Localized Prostate Cancer: Intensity-Modulated Radiation Therapy Versus Conformal Radiation Therapy
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer
JAMA Oncology
Cancer Research
Oncology
Use of Adjuvant 5-Fluorouracil and Radiation Therapy After Gastric Cancer Resection Among the Elderly and Impact on Survival
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy
Oncotarget
Oncology
Systematic Review on the Impact of Pancreatoduodenectomy on Quality of Life in Patients With Pancreatic Cancer
HPB
Hepatology
Gastroenterology
Pharmacogenetics of Toxicity of 5-Fluorouracil, Doxorubicin and Cyclophosphamide Chemotherapy in Breast Cancer Patients
Oncotarget
Oncology
Comparison of Three-Dimensional Conformal Radiation Therapy, Intensity Modulated Radiation Therapy and Helical Tomotherapy for Glioblastoma Multiforme
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Comparison of Adverse Events During 5-Fluorouracil Versus 5-Fluorouracil/Oxaliplatin Adjuvant Chemotherapy for Stage III Colon Cancer
Cancer
Cancer Research
Oncology